Siegfried Holding AG
SFZN
株式のランク
#4106
Siegfried Holding AG, together with its subsidiaries, engages in contract... Siegfried Holding AG, together with its subsidiaries, engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide. It offers drug substances, including exclusive synthesis that manufactures custom APIs. The company also offers an API portfolio, including non-exclusive APIs and pharma-grade substances that focus on anesthetics, pain and addiction treatment applications, and central nervous and respiratory diseases, as well as caffeine for human health and nutrition. In addition, it offers drug products, including steriles, which includes fill and finish in vials, ampoules, cartridges, and pre-filled syringes; ophthalmics, such as sterile ointments, gels, and suspensions and solutions; inhalation products, including capsules in medical devices for inhalation applications; oral solid dosage forms, which includes tablets and capsules; and viral vectors, such as AAV and lentiviruses for gene therapy. Further, the company provides technologies with chemistry capabilities, analytical services, formulation technologies, bridging technologies, containment technology, and cell and gene therapies. The company was founded in 1873 and is headquartered in Zofingen, Switzerland.
株価
$88.34
時価総額
$3.87B
変化（1日）
1.68%
変化（1年）
-12.97%
国
CH
取引 Siegfried Holding AG (SFZN)
カテゴリー
Healthcare
Siegfried Holding AG（SFZN）の営業利益率
October 2026 時点の営業利益率 TTM: 15.73%
Siegfried Holding AG の最新の財務報告と株価によると、現在の営業利益率（TTM）は 15.73% です。2024 年末時点では 15.39% でした。
Siegfried Holding AG の営業利益率の履歴（2002 から 2026）
各年末の営業利益率
| 年 | 営業利益率 | 変化 |
|---|---|---|
| 2026 (TTM) | 15.73% | -0.69% |
| 2025 | 15.84% | 2.92% |
| 2024 | 15.39% | 13.75% |
| 2023 | 13.53% | -26.90% |
| 2022 | 18.51% | 57.00% |
| 2021 | 11.79% | 28.71% |
| 2020 | 9.16% | 39.21% |
| 2019 | 6.58% | -32.65% |
| 2018 | 9.77% | 18.57% |
| 2017 | 8.24% | 47.41% |
| 2016 | 5.59% | -34.39% |
| 2015 | 8.52% | 1.19% |
| 2014 | 8.42% | -3.88% |
| 2013 | 8.76% | 79.88% |
| 2012 | 4.87% | 37.57% |
| 2011 | 3.54% | 107.02% |
| 2010 | 1.71% | -142.01% |
| 2009 | -4.07% | -86.12% |
| 2008 | -29.33% | -406.16% |
| 2007 | 9.58% | -6.26% |
| 2006 | 10.22% | -24.18% |
| 2005 | 13.48% | 86.70% |
| 2004 | 7.22% | -57.97% |
| 2003 | 17.18% | -9.10% |
| 2002 | 18.90% | 0.00% |
同業他社の営業利益率
| 企業 | 営業利益率 | 営業利益率の差 | 国 |
|---|---|---|---|
| 19.41% | -98.77% |
DE
|
|
| 19.68% | -98.75% |
DE
|
|
| 10.52% | -99.33% |
JP
|
|
| 17.08% | -98.91% |
CH
|
|
| 22.93% | -98.54% |
IN
|
企業の営業利益率とは？
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。